169 related articles for article (PubMed ID: 27391361)
1. Relationship between LAPTM4B Gene Polymorphism and Prognosis of Patients following Tumor Resection for Colorectal and Esophageal Cancers.
Cheng X; Tian X; Wu X; Xing X; Du H; Zhou C; Zhang Q; Hao C; Wen X; Ji J
PLoS One; 2016; 11(7):e0158715. PubMed ID: 27391361
[TBL] [Abstract][Full Text] [Related]
2. Relationship between LAPTM4B gene polymorphism and susceptibility of colorectal and esophageal cancers.
Cheng XJ; Xu W; Zhang QY; Zhou RL
Ann Oncol; 2008 Mar; 19(3):527-32. PubMed ID: 17965115
[TBL] [Abstract][Full Text] [Related]
3. LAPTM4B allele *2 is a marker of poor prognosis for gallbladder carcinoma.
Zhai G; Yan K; Ji X; Xu W; Yang J; Xiong F; Su J; McNutt MA; Yang H
PLoS One; 2012; 7(9):e45290. PubMed ID: 22984631
[TBL] [Abstract][Full Text] [Related]
4. Predictive significance of combined LAPTM4B and VEGF expression in patients with cervical cancer.
Meng F; Tan S; Liu T; Song H; Lou G
Tumour Biol; 2016 Apr; 37(4):4849-55. PubMed ID: 26526574
[TBL] [Abstract][Full Text] [Related]
5. LAPTM4B allele *2 is a marker of poor prognosis following hepatic tumor resection for hepatocellular carcinoma.
Yang H; Zhai G; Ji X; Xiong F; Su J; McNutt MA
PLoS One; 2012; 7(4):e34984. PubMed ID: 22509374
[TBL] [Abstract][Full Text] [Related]
6. LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma.
Yang H; Xiong FX; Lin M; Yang Y; Nie X; Zhou RL
J Cancer Res Clin Oncol; 2010 Feb; 136(2):275-81. PubMed ID: 19690886
[TBL] [Abstract][Full Text] [Related]
7. LAPTM4B allele *2 is associated with breast cancer susceptibility and prognosis.
Li X; Kong X; Chen X; Zhang N; Jiang L; Ma T; Yang Q
PLoS One; 2012; 7(9):e44916. PubMed ID: 22984585
[TBL] [Abstract][Full Text] [Related]
8. Relationship between LAPTM4B gene polymorphism and susceptibility of gastric cancer.
Liu Y; Zhang QY; Qian N; Zhou RL
Ann Oncol; 2007 Feb; 18(2):311-6. PubMed ID: 17074969
[TBL] [Abstract][Full Text] [Related]
9. LAPTM4B polymorphisms is associated with ovarian cancer susceptibility and its prognosis.
Xu Y; Liu Y; Zhou R; Meng F; Gao Y; Yang S; Li X; Yang M; Lou G
Jpn J Clin Oncol; 2012 May; 42(5):413-9. PubMed ID: 22412199
[TBL] [Abstract][Full Text] [Related]
10. Lysosomal-associated protein transmembrane 4 Beta-35 overexpression is a novel independent prognostic marker for gastric carcinoma.
Liu L; Xu X; Jing L; Zhou G; Cao Z; Han Y; Zhou R
PLoS One; 2015; 10(2):e0118026. PubMed ID: 25689860
[TBL] [Abstract][Full Text] [Related]
11. Overexpressed LAPTM4B-35 is a risk factor for cancer recurrence and poor prognosis in non-small-cell lung cancer.
Kong F; Gao F; Chen J; Sun Y; Zhang Y; Liu H; Li X; Yang P; Zheng R; Liu G; Jia Y
Oncotarget; 2016 Aug; 7(35):56193-56199. PubMed ID: 27486880
[TBL] [Abstract][Full Text] [Related]
12. LAPTM4B gene polymorphism and endometrial carcinoma risk and prognosis.
Meng F; Li H; Zhou R; Luo C; Hu Y; Lou G
Biomarkers; 2013 Mar; 18(2):136-43. PubMed ID: 23312008
[TBL] [Abstract][Full Text] [Related]
13. Deficient DNA mismatch repair is associated with favorable prognosis in Thai patients with sporadic colorectal cancer.
Korphaisarn K; Pongpaibul A; Limwongse C; Roothumnong E; Klaisuban W; Nimmannit A; Jinawath A; Akewanlop C
World J Gastroenterol; 2015 Jan; 21(3):926-34. PubMed ID: 25624727
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of LAPTM4B: an independent prognostic marker in breast cancer.
Xiao M; Jia S; Wang H; Wang J; Huang Y; Li Z
J Cancer Res Clin Oncol; 2013 Apr; 139(4):661-7. PubMed ID: 23292099
[TBL] [Abstract][Full Text] [Related]
15. LAPTM4B polymorphism is associated with non‑small cell lung cancer susceptibility and prognosis.
Tang H; Tian H; Yue W; Li L; Li S; Gao C; Si L; Qi L; Lu M; Hu W
Oncol Rep; 2014 May; 31(5):2454-60. PubMed ID: 24676601
[TBL] [Abstract][Full Text] [Related]
16. Association of lysosomal protein transmembrane 4 beta gene polymorphism with pancreatic carcinoma susceptibility in the Chinese population.
Wang B; Wang S; Liang G; Xu J; Zhou R; Zhang Q
Tumour Biol; 2017 Jun; 39(6):1010428317705518. PubMed ID: 28618967
[TBL] [Abstract][Full Text] [Related]
17. LAPTM4B-35, a cancer-related gene, is associated with poor prognosis in TNM stages I-III gastric cancer patients.
Cheng X; Zheng Z; Bu Z; Wu X; Zhang L; Xing X; Wang X; Hu Y; Du H; Li L; Li S; Zhou R; Wen XZ; Ji JF
PLoS One; 2015; 10(4):e0121559. PubMed ID: 25849595
[TBL] [Abstract][Full Text] [Related]
18. Lysosome-associated protein transmembrane-4β-35 is a novel independent prognostic factor in small cell lung cancer.
Qiao M; Hu G
Tumour Biol; 2015 Sep; 36(10):7493-9. PubMed ID: 25910706
[TBL] [Abstract][Full Text] [Related]
19. DEK over expression as an independent biomarker for poor prognosis in colorectal cancer.
Lin L; Piao J; Gao W; Piao Y; Jin G; Ma Y; Li J; Lin Z
BMC Cancer; 2013 Jul; 13():366. PubMed ID: 23902796
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of LAPTM4B is correlated with tumor angiogenesis and poor prognosis in non-small cell lung cancer.
Tang H; Tian H; Yue W; Li L; Li S; Gao C; Si L; Qi L; Lu M
Med Oncol; 2014 Jun; 31(6):974. PubMed ID: 24816841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
